Atrial Fibrillation (AF) has become the most prevalent cardiac arrhythmia in the world. Patients are particularly vulnerable to the condition in the five days following cardiac surgery. It is during this time period, where AF could be treated.
Healthcare Professionals: The Rindex Medical A-50 AF Prediction System is an investigational device. AF could be treated prophylactically but typically isn't because clinicians lack a tool for predicting.
Patients: Most clinical statisticians believe that over 2 million people in the United states and over 4 million people in Europe have AF, many of whom have not yet been diagnosed.
Dedicated to developing technology to detect ECG changes that today go unnoticed and provide CVICU clinicians with a tool to predict the onset of AF in the hours before it happens.
In developed nations worldwide, 6.0% of men and 5.1% of women can expect to develop AF during the course of their lives. (The Rotterdam Study 1990-93, n=6,808, Copyright 2012 European Society of Cardiology.)
It's especially likely to alter a patient's course of recovery when it happens in the 5-hour window following heart surgery. Some clinicians call this the "AF Danger Window."
Cardiovascular Intensive Care Units (CVICU) must remain vigilant to notice and treat AF when it occurs. But today, no tool exists to predict the onset of AF before it occurs.
Research performed at the Clevand Clinic now indicates that most cardiac surgery patients who develop AF actually give off clues beforehand - subtle combinations of changes in their ECG reading that are not currently perceptible, even under CVICU best practices today.